Beranda532488 • BOM
add
Divi's Laboratories Ltd
Tutup sebelumnya
₹5.620,80
Rentang hari
₹5.604,30 - ₹5.693,45
Rentang tahun
₹3.350,05 - ₹6.448,75
Kapitalisasi pasar
1,51Â T INR
Volume Rata-Rata
8,28Â rb
Rasio P/E
82,19
Hasil dividen
0,53%
Bursa utama
NSE
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (INR) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 23,38Â M | 22,47% |
Biaya operasional | 7,52Â M | 5,17% |
Laba bersih | 5,10Â M | 46,55% |
Margin laba bersih | 21,81 | 19,64% |
Penghasilan per saham | 19,20 | 46,45% |
EBITDA | 7,15Â M | 49,58% |
Tarif pajak efektif | 29,36% | — |
Neraca
Total aset
Total liabilitas
| (INR) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 36,02Â M | -0,25% |
Total aset | 155,86Â M | 9,12% |
Total liabilitas | 18,69Â M | 16,38% |
Total ekuitas | 137,17 M | — |
Saham yang beredar | 265,62 jt | — |
Harga terhadap nilai buku | 10,88 | — |
Tingkat pengembalian aset | — | — |
Tingkat pengembalian modal | 11,30% | — |
Arus Kas
Perubahan kas bersih
| (INR) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 5,10Â M | 46,55% |
Kas dari operasi | — | — |
Kas dari investasi | — | — |
Kas dari pembiayaan | — | — |
Perubahan kas bersih | — | — |
Arus kas bebas | — | — |
Tentang
Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients and intermediates, headquartered in Hyderabad. The company manufactures and custom synthesizes generic APIs, intermediates. The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals. Divi's Laboratories is India's fourth largest publicly listed pharmaceutical company by market capitalization.
In October 2024, Divi and his family were ranked 29th on Forbes list of India’s 100 richest tycoons, with a net worth of $9.2 billion. Wikipedia
Didirikan
12 Okt 1990
Situs
Karyawan
9.741
